Journal profile · Oncology
International Journal of Oncology
ISSN 1019-6439 · eISSN 1791-2423 · Spandidos Publications · GREECE · Monthly · Founded 1992
International Journal of Oncology: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 7.19; hybrid open access; median 117 days to acceptance (69 articles, last 24 months); community-reported acceptance: about 62.5%; 127 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
International Journal of Oncology is published by Spandidos Publications and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Cancer-related Molecular Pathways, RNA modifications and cancer and Cancer-related molecular mechanisms research, together about 20.4% of its articles. Its main subfields are Molecular Biology and Cancer Research. (generated from OpenAlex topic counts and CAS ranking data)
Spandidos Publications is a scientific publisher with a long-standing international reputation for excellent standards and high quality science publications
From the journal's Aims & Scope
Research area (LetPub): Oncology
Editor-in-chief DEMETRIOS A. SPANDIDOSPublisher website
Editorial board by country: none in mainland China; most named Italy 6, Japan 5, Greece 4, Saudi Arabia 3, United Kingdom 2 (26 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Cancer-related Molecular PathwaysMedicine7.6%
- RNA modifications and cancerBiochemistry, Genetics and Molecular Biology6.5%
- Cancer-related molecular mechanisms researchBiochemistry, Genetics and Molecular Biology6.3%
- MicroRNA in disease regulationBiochemistry, Genetics and Molecular Biology6%
- Cancer, Hypoxia, and MetabolismBiochemistry, Genetics and Molecular Biology5.7%
- Cancer Cells and MetastasisMedicine5.2%
- Epigenetics and DNA MethylationBiochemistry, Genetics and Molecular Biology4.5%
- Cancer-related gene regulationBiochemistry, Genetics and Molecular Biology4.4%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Oncology | Zone 3 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Oncology | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Oncology | Zone 3 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 7.19LetPub ·
- Impact factor (publisher)
- 7.3Publisher website ·
- CiteScore 2026-06
- 10.2LetPub ·
- CiteScore (publisher)
- 10.2Publisher website ·
- SJR 2026-06
- 1.41LetPub ·
- SNIP 2026-06
- 1.07LetPub ·
- h-index
- 111LetPub ·
- h-index
- 155OpenAlex ·
- i10-index
- 8,295OpenAlex ·
- 2-year mean citedness
- 12.46OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 90.75%LetPub ·
Volume
- Articles per year
- 72LetPub ·
Articles by year OpenAlex count · 11,542 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 100 | 99 | 2,373 |
| 2025 | 127 | 123 | 450 |
| 2024 | 109 | 109 | 1,362 |
| 2023 | 135 | 134 | 2,215 |
| 2022 | 172 | 170 | 2,968 |
| 2021 | 135 | 133 | 3,702 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
117 daysMedian, submission to acceptance · P25–P75 86 days – 162 days
- Acceptance to online
- median 38 days (69 articles)
- Submission to online
- median 178 days
- Sample
- 69 articles with submission and acceptance dates (251 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 2.1 monthsLetPub ·
- Average acceptance (community reports)
- 62.5%LetPub ·
- Peer review
- Single-anonymous peer reviewPublisher website · model-extracted
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
No source has fee information yet; check the journal's website.
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
Other charges and waivers (author guidelines)
- Page charges
- EUR 110
- Submission fee
- EUR 550
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare8 items from the author guidelines
- Abstract
- 150–300 words
- Keywords
- 5–10
- Reference style
- Numbered, in order of citation
- First submission
- Free format: the journal's layout is not required
- Suggested reviewers
- Optional
- Highlights
- Optional
- Graphical abstract
- Optional
- Cover letter
- Required
Policy excerpts from the journal's websiteAI use, Conflicts of interest, Data availability, Publication ethics, License & copyright, Open access, Plagiarism, Self-archiving
- AI use Use of artificial intelligence tools
Authors should disclose the use of artificial intelligence (AI)-assisted tools such as chatGPT in the Declarations section (e.g. ‘Use of artificial intelligence tools - During the preparation of this work, AI tools were used to improve the readability and language of the manuscript or to generate images, and subsequently, the authors revised and edited the content produced by the AI tools as neces…
Source ↗Publisher website ·- Conflicts of interest Competing interests
Authors, reviewers and editors must disclose any competing interests that may exist with respect to the publication of a study. Competing interests are at play if the interpretation and presentation of the data, the conclusions or any other information provided by the authors can be influenced (or may be perceived as such) by their personal or financial relationship with other individuals or organ…
Source ↗Publisher website ·- Data availability Availability of data and materials
Data must be made freely available to researchers Model summary
For all manuscripts submitted to Spandidos Publications, the authors must make provisions for all materials described in their manuscript, including all relevant raw data, to be freely available to any researchers who may wish to reuse or reanalyze them. If any conclusions made in the paper depend on a particular, dataset, then this dataset must be made available to the readers (unless it is alrea…
Source ↗Publisher website ·- Publication ethics
Human research must follow Declaration of Helsinki Model summary
Research performed on human subjects, materials or data must follow international and national regulations and be in agreement with the Declaration of Helsinki, or any other relevant set of ethical principles.
Source ↗Publisher website ·- License & copyright 3.3.9 Copyright
If a figure or table has been published previously (even if you were the author of the manuscript), copyright permission for re-use of the figure or table will often be required. You must acknowledge the original source and submit written permission from the copyright holder to reproduce the material where necessary. As an author of your manuscript, you are responsible for obtaining permissions to…
Source ↗Publisher website ·- Open access 7. Open access
"Open access" articles published online can be freely accessed at the journal's website by all users. The articles are made immediately available as Open access and appear online at PubMed, PubMed Central and Europe PMC. Articles may be licensed under a Creative Commons Attribution-NonCommercial- NoDerivatives 4.0 International License, a Creative Commons Attribution-NonCommercial 4.0 Internationa…
Source ↗Publisher website ·- Plagiarism
Uses iThenticate for plagiarism screening Model summary
Spandidos Publications uses iThenticate to screen submitted manuscripts against previously published studies and other relevant sources.
Source ↗Publisher website ·- Self-archiving 10. Author self-archiving
Authors are encouraged to submit the final publisher’s version PDF of their manuscript to their institution’s repository 6 months following publication, as well as to their funding body’s archive. A link to the published version on the Spandidos Publications website must be included with full citation details and acknowledgement of the journal as the original source. Authors that have purchased Op…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Spandidos Publications
- Country or region
- GREECE
- Language
- English
- Frequency
- Monthly
- Founded
- 1992
- ISSN
- 1019-6439
- Electronic ISSN
- 1791-2423
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
- Special issues ↗Publisher website
FAQ
Frequently asked questions about International Journal of Oncology
What CAS zone is International Journal of Oncology in?
In the 2025 upgraded edition of the CAS Journal Ranking, International Journal of Oncology is in Zone 3 of Medicine, and in Zone 3 of the minor category Oncology. In the 2026 Xinrui edition it is in Zone 2 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of International Journal of Oncology?
The latest impact factor listed by LetPub is 7.19; CiteScore 10.2, h-index 155.
How long does peer review take at International Journal of Oncology?
Based on the dates recorded on 69 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 117 days (interquartile range 86–162 days); authors report an average review time of about 2.1 months; the community-reported acceptance is “about 62.5%”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of International Journal of Oncology?
According to the journal's author guidelines: Abstract: 150–300 words; Keywords: 5–10; Reference style: Numbered, in order of citation; First submission: Free format: the journal's layout is not required; Suggested reviewers: Optional; Highlights: Optional; Graphical abstract: Optional; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of International Journal of Oncology based?
Of the 26 board members whose country the journal's board page names, none are in mainland China; the countries named most often are Italy (6), Japan (5) and Greece (4). Counted from the institutions listed on the board page; for reference only.
Which databases index International Journal of Oncology?
According to LetPub and DOAJ records, International Journal of Oncology is indexed in SCIE and Scopus.
Is International Journal of Oncology open access, and what is the APC?
International Journal of Oncology is a hybrid journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .